EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,520,000 | -11.8% | 50,000 | -28.6% | 0.29% | -40.5% |
| Q2 2017 | $1,724,000 | +44.5% | 70,000 | -12.5% | 0.48% | +8.6% |
| Q4 2016 | $1,193,000 | -7.1% | 80,000 | -75.1% | 0.44% | -38.2% |
| Q1 2016 | $1,284,000 | -81.2% | 320,897 | -73.4% | 0.72% | -78.0% |
| Q4 2015 | $6,812,000 | -35.4% | 1,207,726 | -35.8% | 3.26% | -46.6% |
| Q3 2015 | $10,547,000 | +1146.7% | 1,880,004 | +471.4% | 6.11% | +756.4% |
| Q1 2015 | $846,000 | – | 329,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |